Archive · 19 Jan 2026
Single-dose IV iron drip helps combat rising anaemia in pregnancy
Anaemia is a condition where the body doesn't have enough healthy red blood cells.
In pregnant women, it can lead to problems like premature birth and low birth weight.
Doctors usually give iron and folic acid tablets, but many women don't take them regularly because they cause stomach issues.
Now, there's a new treatment called IV iron, which is given through a drip.
It only needs to be given once, and it works better than tablets.
Two states in India, Rajasthan and Karnataka, have started using this treatment.
It's also become cheaper, so more people can use it.
This is important because anaemia is becoming more common, especially in pregnant women and young children.
Single-dose IV iron (Ferric Carboxymaltose) is being introduced to treat severe anaemia in pregnant women.
Rajasthan and Karnataka have started implementing this treatment under the Anaemia Mukt Bharat programme.
The new IV iron supplement is more effective and convenient than oral iron supplements, which have poor compliance due to gastrointestinal side effects.
The cost of IV iron has decreased significantly after it came off patent, making it more accessible for public health programmes.
Anaemia prevalence has increased in recent years, with 52.2% of pregnant women and 67.1% of children aged 6-59 months affected.
- Who
- Pregnant women in Rajasthan and Karnataka
- What
- Introduction of single-dose IV iron (Ferric Carboxymaltose) to treat severe anaemia
- When
- Pilot launched in December 2023
- Where
- Rajasthan and Karnataka, India
- Why
- To combat rising anaemia in pregnancy and improve maternal and child health outcomes
- Condition
- Anaemia in pregnancy
- Treatment
- Single-dose IV iron (Ferric Carboxymaltose)
- Effectiveness
- Corrects anaemia in pregnant mothers
- Cost
- Rs 170 (after patent expiry)
- States Implementing
- Rajasthan, Karnataka
- Anaemia Prevalence (Pregnant Women)
- 52.2% (2019-2021)
- Anaemia Prevalence (Women 15-49)
- 57% (2019-2021)
- Anaemia Prevalence (Children 6-59 months)
- 67.1% (2019-2021)